{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:55:30Z","timestamp":1793357730541,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017174","name":"Spanish Association of Coloproctology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.esmoop.2026.108250","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:24:05Z","timestamp":1782858245000},"page":"108250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["ELECLA trial: final results of perioperative chemotherapy with fluoropyrimidine and oxaliplatin in mismatch repair proficient locally advanced colon cancer"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8077-6092","authenticated-orcid":false,"given":"J.","family":"Arredondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5025-6069","authenticated-orcid":false,"given":"D.","family":"Aliseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Casta\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-2279","authenticated-orcid":false,"given":"M.","family":"Muinelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-9326","authenticated-orcid":false,"given":"C.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-9126","authenticated-orcid":false,"given":"L.","family":"Garc\u00eda Fl\u00f3rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2142-4737","authenticated-orcid":false,"given":"V.","family":"Vigorita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gallar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8593-4878","authenticated-orcid":false,"given":"M.","family":"Tasende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ruiz de la Hermosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3600-0868","authenticated-orcid":false,"given":"C.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"N\u00fa\u00f1ez-C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-4384","authenticated-orcid":false,"given":"J.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Villafa\u00f1e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Cifri\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Elosua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Turienzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Magdaleno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Matanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chopitea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Baixauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fern\u00e1ndez Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmoop.2026.108250_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108250_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108250_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108250_bib4","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1177\/00031348231175490","article-title":"Current controversies in the management of locally advanced colon cancer","volume":"89","author":"Gillani","year":"2023","journal-title":"Am Surg"},{"key":"10.1016\/j.esmoop.2026.108250_bib5","series-title":"NCCN Clinical Practice Guidelines in Oncology: Colon Cancer","author":"Adam","year":"2024"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108250_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108250_bib7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1200\/JCO.21.02538","article-title":"Adjuvant therapy for stage II colon cancer: ASCO guideline update","volume":"40","author":"Baxter","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.2009.24.0952","article-title":"Revised TN categorization for colon cancer based on national survival outcomes data","volume":"28","author":"Gunderson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.esmoop.2026.108250_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III colon cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108250_bib10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10151-020-02289-4","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review","volume":"24","author":"Arredondo","year":"2020","journal-title":"Tech Coloproctol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108250_bib11","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00384-021-03945-3","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis","volume":"36","author":"Gosavi","year":"2021","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108250_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.21037\/jgo-20-220","article-title":"Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review","volume":"11","author":"Cheong","year":"2020","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108250_bib13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.22.00046","article-title":"Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial","volume":"41","author":"Morton","year":"2023","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.esmoop.2026.108250_bib14","article-title":"Neoadjuvant chemotherapy versus standard treatment in locally advanced colon cancer: the NeoCol phase III trial","volume":"41","author":"Jensen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.esmoop.2026.108250_bib15","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1200\/JCO.23.01889","article-title":"Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase III OPTICAL trial","volume":"42","author":"Hu","year":"2024","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108250_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/codi.15585","article-title":"Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk stage II and III colon cancers? Three years\u2019 follow-up results of the PRODIGE 22 phase II randomized multicentre trial","volume":"23","author":"Karoui","year":"2021","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108250_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/SLA.0000000000004494","article-title":"Diverting stoma followed by neoadjuvant mFOLFOX6 for obstructive colon cancer: YCOG1305 trial","volume":"276","author":"Ishibe","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.esmoop.2026.108250_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12885-020-6560-x","article-title":"Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer","volume":"20","author":"Han","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108250_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/codi.12119","article-title":"Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer","volume":"15","author":"Arredondo","year":"2013","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib20","first-page":"104","article-title":"Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy","volume":"5","author":"Arredondo","year":"2014","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108250_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12094-016-1539-4","article-title":"Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery","volume":"19","author":"Arredondo","year":"2017","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108250_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/codi.16908","article-title":"The ELECLA trial: a multicentre randomised control trial on outcomes of neoadjuvant treatment on locally advanced colon cancer","volume":"26","author":"Arredondo","year":"2024","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae021","article-title":"Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis","volume":"111","author":"Aliseda","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.esmoop.2026.108250_bib58","series-title":"TNM Classification of Malignant Tumours","year":"2025"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.esmoop.2026.108250_bib27","series-title":"Common Terminology Criteria for Adverse Events (CTCAE), version 4.0","year":"2009"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/DCR.0000000000002323","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer","volume":"65","author":"Vogel","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.esmoop.2026.108250_bib29","series-title":"Colorectal Cancer Guideline (NG151)","year":"2020"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108250_bib30","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.22.02108","article-title":"FOxTROT: are we ready to dance?","volume":"41","author":"Taieb","year":"2023","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108250_bib31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/codi.16945","article-title":"Colon cancer: feeling the imbalance?","volume":"26","author":"Ballal","year":"2024","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108250_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/codi.16545","article-title":"Colon cancer care is changing and not before time","volume":"25","author":"Smart","year":"2023","journal-title":"Colorectal Dis"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108250_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/SLA.0000000000003454","article-title":"Perioperative FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a phase II multicenter randomized controlled trial (PRODIGE 22)","volume":"271","author":"Karoui","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.esmoop.2026.108250_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115476","article-title":"Neoadjuvant chemotherapy for colon cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"222","author":"Noronha","year":"2025","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108250_bib35","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1245\/s10434-025-17640-y","article-title":"Oncological outcomes of neoadjuvant chemotherapy versus upfront surgery in locally advanced colon cancer: a systematic review, meta-analysis, and sequential analysis","volume":"32","author":"Sassun","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"16 suppl","key":"10.1016\/j.esmoop.2026.108250_bib36","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1200\/JCO.2022.40.16_suppl.3511","article-title":"Neoadjuvant nivolumab, ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: final clinical analysis of the NICHE study","volume":"40","author":"Verschoor","year":"2022","journal-title":"J Clin Oncol"},{"issue":"44","key":"10.1016\/j.esmoop.2026.108250_bib37","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1038\/s41388-023-02835-y","article-title":"Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer","volume":"42","author":"Kasi","year":"2023","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.esmoop.2026.108250_bib38","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2012.385","article-title":"Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial","volume":"307","author":"Alberts","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108250_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.2010.30.0855","article-title":"Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08","volume":"29","author":"Allegra","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108250_bib40","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3109\/0284186X.2015.1037007","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial","volume":"54","author":"Jakobsen","year":"2015","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108250_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/codi.16487","article-title":"Personalizing neoadjuvant chemotherapy for locally advanced colon cancer: protocols for the international phase III FOxTROT2 and FOxTROT3 randomized controlled trials","volume":"25","author":"Platt","year":"2023","journal-title":"Colorectal Dis"},{"issue":"4 suppl","key":"10.1016\/j.esmoop.2026.108250_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2025.43.4_suppl.158","article-title":"Preoperative botensilimab (BOT) with or without balstilimab (BAL) for patients with resectable locally advanced pMMR or dMMR colon cancer: results from the UNICORN trial by GONO","volume":"43","author":"Ghelardi","year":"2025","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108250_bib43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00268-019-04950-y","article-title":"Prehabilitation before major abdominal surgery: a systematic review and meta-analysis","volume":"43","author":"Hughes","year":"2019","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108250_bib44","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDra2400012","article-title":"Enhanced recovery after surgery - evidence and practice","volume":"4","author":"Elias","year":"2025","journal-title":"NEJM Evid"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108250_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11864-024-01184-6","article-title":"Preoperative strategies for locally advanced colon cancer","volume":"25","author":"Nair","year":"2024","journal-title":"Curr Treat Options Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108250_bib46","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s11605-018-3777-y","article-title":"Correlation between clinical and pathologic staging in colon cancer: implications for neoadjuvant treatment","volume":"22","author":"Dehal","year":"2018","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108250_bib47","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/sj.bjc.6603646","article-title":"Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials","volume":"96","author":"Smith","year":"2007","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108250_bib48","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.31440","article-title":"Diagnostic performance of MRI and FDG PET\/CT for preoperative locoregional staging of colon cancer: systematic review and meta-analysis","volume":"223","author":"Sikkenk","year":"2024","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108250_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16987","article-title":"Assessment of a staging system for sigmoid colon cancer based on tumor deposits and extramural venous invasion on computed tomography","volume":"2","author":"D\u2019Souza","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1146","key":"10.1016\/j.esmoop.2026.108250_bib50","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220682","article-title":"Inter-rater agreement between radiologists using the novel CT-TDV (T3c+; tumour deposits; EMVI) system in patients with potentially curable right colon cancer","volume":"96","author":"Hodges","year":"2023","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib51","first-page":"300","article-title":"Treatment adherence to adjuvant chemotherapy according to the new standard 3-month CAPOX regimen in high-risk stage II and stage III colon cancer: a population-based evaluation in the Netherlands","volume":"24","author":"van den Berg","year":"2025","journal-title":"Clin Colorectal Cancer"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108250_bib52","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.2011.749","article-title":"Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis","volume":"305","author":"Biagi","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108250_bib53","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s12094-023-03138-0","article-title":"Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery","volume":"25","author":"Zozaya","year":"2023","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108250_bib54","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1245\/s10434-014-4051-5","article-title":"Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery","volume":"22","author":"Cienfuegos","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108250_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/SLA.0000000000006145","article-title":"Risk of bowel obstruction in patients undergoing neoadjuvant chemotherapy for high-risk colon cancer: a nested case-control-matched analysis of an international, multicenter, randomized controlled trial (FOxTROT)","volume":"280","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.esmoop.2026.108250_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114230","article-title":"Challenges of estimating treatment effects after a positive interim analysis","volume":"209","author":"Soon","year":"2024","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108250_bib57","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ejso.2021.02.020","article-title":"D3-lymphadenectomy enhances oncological clearance in patients with right colon cancer. Results of a meta-analysis","volume":"47","author":"Balciscueta","year":"2021","journal-title":"Eur J Surg Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926021927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926021927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:21:55Z","timestamp":1784546515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926021927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2059702926021927"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108250","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ELECLA trial: final results of perioperative chemotherapy with fluoropyrimidine and oxaliplatin in mismatch repair proficient locally advanced colon cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108250"}}